Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Johnson & Johnson (NY: JNJ)
141.34 USD  +0.36 (+0.26%)
Official Closing Price  /  Updated: 7:06 PM EST, Dec 12, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 5,012,506
Open 141.32
Bid (Size) 141.30 (1)
Ask (Size) 142.00 (9)
Prev. Close 140.98
Today's Range 140.73 - 142.06
52wk Range 121.00 - 148.59
Shares Outstanding 2,682,149,964
Dividend Yield 2.46%
Performance
YTD
+10.64%
+10.64%
1 Month
+7.61%
+7.61%
3 Month
+8.36%
+8.36%
6 Month
+0.45%
+0.45%
1 Year
-3.92%
-3.92%
Top News
More News
Diversity & Inclusion Is a Business Imperative
category Diversity & inclusion , Diversity & Inclusion , johnson & johnson , and 2 more.
from 3BL Media: Corporate Social Responsibility, Energy and Health News
From Doctor to Researcher: Meet a Woman Who's Spent Much of Her Career Fighting Prostate Cancer
category Improving Healthcare Access , Prostate Cancer Research , Responsible Business & Employee Engagement , and 7 more.
from 3BL Media: Corporate Social Responsibility, Energy and Health News
More News
Read More
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
from PR Newswire
QUAL, JNJ, PEP, MMM: Large Inflows Detected at ETF
category ETFs
from ETF Channel
Here's Why Assembly Biosciences Stock Is Soaring Today
category JNJ , Market News , ARWR , and 1 more.
from Motley Fool
ISRG Stock: Should You Invest In This Robotic Surgery Giant?
from Investor's Business Daily
Will This Biotech Company Soon Nab Another Gene Therapy Approval?
from Investor's Business Daily
3 Biotech Stocks That Can Double Your Money in 2020
category TNDM , PFE , DXCM , and 4 more.
from Motley Fool
Investors shift attention to next generation of CAR-T, new sickle cell treatments at major hematology meeting
category GILD , ARQL , MRK , and 7 more.
from MarketWatch
UPDATE 1-J&J CEO spurns U.S. congressional hearing on carcinogens in talc products
category companyNews
from Reuters: Company News
J&J CEO Gorsky spurns U.S. congressional hearing on carcinogens in talc products
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.